arrow
T

Thomas S. Uldrick

harvard university medical affiliates
H指数:47
被引数:9,450

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy

抗PD-1疗法后与HIV储库衰减相关的固有抗病毒和免疫功能

2026-02-011
PRE
Characteristics and outcomes of Kaposi sarcoma herpesvirus (KSHV)-associated inflammatory cytokine syndrome (KICS)

卡波西肉瘤相关疱疹病毒(KSHV)诱导的炎症细胞因子综合征(KICS)的特征和结局

2025-08-070
OAAI
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma

I期研究:efineptakin alfa (NT-I7)治疗Kaposi肉瘤

2025-02-060
OA
Sequencing of Kaposi's Sarcoma Herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infections, novel polymorphisms, and low intra-host variance
2024-07-153
OAAI
Ubamatamab (MUC16xCD3 bispecific antibody) with cemiplimab (anti-PD-1 antibody) in recurrent ovarian cancer: Phase I dose-escalation study

Ubamatamab (MUC16xCD3双特异性抗体) 联合cemiplimab (anti-PD-1抗体) 治疗复发性卵巢癌: I期剂量递增研究

2023-10-013
OA
Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis
2023-09-225
OAAI
Circulating tumor DNA (ctDNA) correlates closely with tumor necrosis and relapsefree survival (RFS) in hepatocellular carcinoma (HCC) patients treated with perioperative cemiplimab
2023-04-040
PRE
Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseases

卡波西肉瘤疱疹病毒相关疾病患者入住ICU的特征

AIDS
IF3.1
2022-07-1612
OA
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy
2022-01-2659
OA